BridgeBio to Participate in December Investor Conferences

Rhea-AI Summary

BridgeBio (Nasdaq: BBIO) said members of management will participate in two December investor fireside chats: Piper Sandler Healthcare Conference in New York on Tuesday, December 2 at 10:30 AM ET, and EvercoreISI HealthCONx Conference in Miami on Wednesday, December 3 at 3:00 PM ET.

Live webcasts will be available on the company’s Investors > Events and Presentations page, with replays accessible on the BridgeBio website for 90 days after each event.

PALO ALTO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences:

• Piper Sandler Healthcare Conference, New York, NY: Fireside Chat on Tuesday, December 2 at 10:30 am EST
• EvercoreISI HealthCONx Conference, Miami, FL: Fireside Chat on Wednesday, December 3 at 3:00 pm EST

To access the live webcast of BridgeBio’s presentations, please visit the “Events and Presentations” page within the Investors section of the BridgeBio website at https://investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.

About BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (BridgeBio; Nasdaq: BBIO) is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn, X, Facebook, Instagram, and YouTube. 

BridgeBio Media Contact:
Bubba Murarka, Executive Vice President, Corporate Development
contact@bridgebio.com  
(650)-789-8220

BridgeBio Investor Contact:
Chinmay Shukla, Senior Vice President, Strategic Finance
ir@bridgebio.com

FAQ

When will BridgeBio (BBIO) present at the Piper Sandler Healthcare Conference?

BridgeBio will present a fireside chat on December 2, 2025 at 10:30 AM ET.

What time is BridgeBio (BBIO) scheduled to speak at EvercoreISI HealthCONx?

The fireside chat is scheduled for December 3, 2025 at 3:00 PM ET.

How can investors watch BridgeBio (BBIO) live webcasts for the December 2025 presentations?

Watch live via the Events and Presentations page in the Investors section of BridgeBio’s website.

Will there be a replay of BridgeBio (BBIO) investor presentations and for how long?

Yes. Replays will be available on BridgeBio’s website for 90 days after each event.

Which BridgeBio (BBIO) executives will participate in the December investor fireside chats?

The company announced that members of its management team will participate; specific names were not provided in the announcement.

Can institutional investors access the BridgeBio (BBIO) conference webcasts on demand after December 2025?

Yes. Replays are posted on the BridgeBio investor website and remain available for 90 days after each presentation.